Insulin degludec Subcutaneous and Lomitapide Mesylate
Determining the interaction of Insulin degludec Subcutaneous and Lomitapide Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: lomitapide
Brand name: Juxtapid
Synonyms: Lomitapide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Lomocot
- Insulin degludec Subcutaneous-Lomotil
- Insulin degludec Subcutaneous-Lomotil (Diphenoxylate and Atropine Solution)
- Insulin degludec Subcutaneous-Lomotil (Diphenoxylate and Atropine Tablets)
- Insulin degludec Subcutaneous-Lomustine
- Insulin degludec Subcutaneous-Long Lasting Nasal Spray
- Lomitapide Mesylate-Insulin detemir
- Lomitapide Mesylate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Lomitapide Mesylate-Insulin Detemir (Vials)
- Lomitapide Mesylate-Insulin detemir Subcutaneous
- Lomitapide Mesylate-Insulin glargine
- Lomitapide Mesylate-Insulin Glargine (U-100) Cartridge Systems and Pens